BRIDGEWATER, N.J.--(BUSINESS WIRE)--Feb. 28, 2006--Enzon Pharmaceuticals, Inc. (Nasdaq: ENZN) today announced its financial results for the quarter ended December 31, 2005, the second quarter of Enzon's six-month transition period ended December 31, 2005. As previously reported, Enzon announced a change in its fiscal year-end from June 30 to December 31.
